Public Policy Letters, Statements, Legal Briefs, & Other Responses
← Back to all Letters & Statements
-
Sign-on Letter to Evicore Regarding Interpretation of NCCN Guidelines
-
Sign-on Letter Regarding the Novitas & FCSO Proposed LCD on Genetic Testing for Oncology
-
Sign-on Letter Supporting the Reducing Hereditary Cancer Act
-
ACMG Response to USPSTF Proposed Research Plan for Lynch Syndrome
-
Group Sign-on Letter to Congress Supporting the Reducing Hereditary Cancer Act
-
ACMG Letter to CMS Requesting Reconsideration of Payment Determination for a PALB2 CPT Code 81307
-
ACMG Comments to CMS about Proposed Decision for Medicare Coverage of NGS for Advanced Cancer
-
ACMG Comments to CMS Regarding NCD 90.2 and Medicare Coverage of NGS for Advanced Cancer
-
Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer